CMS just reported something worth pausing on: the Medicare Shared Savings Program saved $2.5 billion in 2025. That figure—spread across 511 participating ACOs representing more than 700,000 providers—marks the MSSP's strongest year since the program's expansion. And it comes at exactly the moment when every serious ACO is building toward the LEAD model's January 1, 2027 launch.
The headline number is good news. But behind it is a distribution story that most ACOs aren't reading carefully enough. Some organizations captured shared savings at 3–5% of their benchmark. Others, with comparable patient populations, generated none. The gap between them wasn't clinical capability. It was operational infrastructure.
What follows is a breakdown of what drove the $2.5B figure—and five specific operational gaps that separate ACOs that will thrive in LEAD from those that won't.
What the $2.5B Actually Tells Us
CMS's figure is a net number: gross savings generated by high-performing ACOs, offset by shared losses from ACOs in the downside-risk track. The gross is significantly higher. That spread matters because LEAD changes the risk calculus substantially—all LEAD participants enter with downside exposure starting in performance year 1.
What drove the $2.5B? Three factors recur in every high-performing MSSP ACO's operational profile:
- Annual Wellness Visit completion above 70%. AWVs are the primary mechanism for HCC capture, care plan updates, and referral closure. ACOs with sub-50% AWV rates consistently underperform on both quality and benchmarking.
- Post-discharge follow-up within 7 days. Avoidable readmissions remain the single largest driver of spending variance between high and low performers. The 7-day window is well-established; closing it at scale requires automation.
- HEDIS measure performance above the 50th percentile on at least 8 of 10 tracked measures. Quality bonuses in MSSP—now scaling further in LEAD under the new 75% shared savings adjustment factor from the CMS 2027 Physician Fee Schedule final rule—compound the financial impact of care gap closure.
Lesson 1: AWV Completion Is Your Benchmark Floor
The relationship between AWV completion and shared savings performance isn't correlative—it's structural. CMS's risk adjustment model, in its ongoing transition from HCC V24 to V28, rewards documentation completeness. An AWV is the highest-yield documentation touchpoint in the ambulatory care calendar. It surfaces RAF-driving diagnoses, triggers transitional care flags, and creates the annual update that justifies chronic care management enrollment.
Zynix customers report a 22 to 25% increase in AWVs from baseline (customer reported). The mechanism is straightforward: automated outreach to patients who haven’t scheduled, real-time gap lists surfaced directly in care managers’ workflows, and documentation captured back into the EHR.
If your ACO is heading into LEAD year 1 with AWV completion below 60%, that is not a clinical problem. It is a workflow problem—and it has a tractable solution.
Lesson 2: HEDIS Performance Compounds, and December Is Too Late to Start
ACOs that enter the year-end quality sprint in October are already behind. The highest-performing MSSP participants run continuous gap identification—not campaigns, not point-in-time audits. They know, in real time, which members are open on HbA1c control, which are overdue on breast cancer screening, and which eye exam gap can be closed with a single outreach touchpoint.
The practical move is to prioritize high-yield, low-barrier gaps (colorectal cancer screening, controlling blood pressure, medication adherence) and close them through automated outreach with provider attribution. Outreach helps most on measures where patient activation, not provider action, is the main lever.
If you're still running HEDIS as a December project, you're leaving 8–12 quality points on the table every year. LEAD's performance structure makes those points financially material. For a practical closure calendar, see our guide on closing HEDIS quality gaps before December 31.
Lesson 3: Dual-Eligible Populations Are the Hidden Swing Factor
CMS's $2.5B result averages across extraordinarily varied patient populations. ACOs with high dual-eligible concentrations face a structural challenge: these members generate the highest total cost of care, but they also carry the highest documentation complexity, the most fragmented care patterns, and the greatest sensitivity to social determinants affecting utilization.
For dual-eligible members, the conventional care management playbook (telephonic outreach, manual care plans, episodic touchpoints) often produces poor engagement and persistent downstream cost variance. A better pattern gives care managers member-level context before each conversation: utilization history, medication burden and upcoming care gaps, turned into specific, actionable talking points.
In LEAD, this population will drive a disproportionate share of spending variance. Organizations that have not operationalized high-touch, AI-assisted workflows for their dual-eligible panels are carrying a risk they may not fully see until year-end reconciliation.
Lesson 4: Care Management Scale Requires Automation, Not Headcount
The economics of MSSP have always required ACOs to manage large, attributed populations with lean care management teams. LEAD intensifies this—its 10-year performance window rewards organizations that build durable operational infrastructure, not those that spike headcount during performance years and lose capacity during contract cycles.
The scalable model has AI agents handle outreach, follow-up scheduling, documentation routing and escalation triage within defined protocols, escalating exceptions to people, without adding care manager FTEs. Care managers focus on the highest-acuity conversations: the ones that need clinical judgment, motivational interviewing and care plan changes. Agents never make clinical decisions.
This is what scaled care management looks like in 2026. It is not a point solution. It is an operating model—and it is the only one that will hold at LEAD scale across a 10-year performance window.
Lesson 5: Pediatric and Commercial Populations Require Different Quality Logic
Not every ACO's attributed population is predominantly Medicare FFS seniors. ACOs that also manage commercial and pediatric populations—through MSO arrangements, hybrid contracts, or MA-adjacent structures—face a different set of HEDIS measures and a different outreach calculus entirely.
Pediatric populations face a different measure set: well-child visits, developmental screenings and immunizations. The hard part is not finding the gap; it is reaching the right parent or guardian at the right time, on the channel they prefer.
If your ACO's LEAD attribution will include pediatric or commercial lives, build your quality infrastructure accordingly. The measures are different, the levers are different, and the timelines don't map to the Medicare FFS calendar.
What LEAD Changes About All of This
The MSSP $2.5B result is a 2025 snapshot. LEAD changes the game starting January 1, 2027—and the structural differences in benchmarking methodology, risk track design, and performance incentives are significant. For a full breakdown of how MSSP and LEAD differ, see our explainer on how MSSP benchmarks differ from LEAD's methodology.
The five operational lessons above are not MSSP-specific. They apply with even greater force in a 10-year performance environment where infrastructure decisions made in year 1 compound—positively or negatively—across the entire contract period. Organizations that enter LEAD with weak AWV workflows, manual care management, and reactive quality programs will not fix those problems under performance pressure. They need to fix them now.
The $2.5B is evidence that accountable care works at scale. The question is whether your organization is positioned to contribute to—and capture a share of—the next ten years of it.
If you're running an ACO, MSO, or value-based contract and this applies to your org—
You're heading into LEAD Year 1 with AWV completion below 65%, a care management team stretched too thin to run continuous gap closure, and no automated outreach layer connecting your attributed population to your care managers.
Bring your three hardest VBC operational problems to a 15-minute call with the Zynix team. No slide deck.
Book a free care gap opportunity analysis: zynix.ai/cclf-opportunity-analysis